These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 4337628)

  • 1. Assay of neutralizing antibody against variola virus by the degree of focus reduction on HeLa cell cultures and its application to revaccination with smallpox vaccines of various potencies.
    Kitamura T; Shinjo N
    Bull World Health Organ; 1972; 46(1):15-26. PubMed ID: 4337628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of variola virus on microtiter plates and its application to the neutralization test.
    Kitamura T; Tanaka Y
    Bull World Health Organ; 1973; 49(3):251-6. PubMed ID: 4367778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiments on the challenge of the antivaccinial transfer immunity of cell cultures by infection with variola virus. (Evaluation of the antivariola potency of smallpox vaccines)].
    Stickl H
    Zentralbl Bakteriol Orig; 1968; 208(4):473-85. PubMed ID: 4329545
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-related effects of smallpox vaccine.
    Frey SE; Newman FK; Cruz J; Shelton WB; Tennant JM; Polach T; Rothman AL; Kennedy JS; Wolff M; Belshe RB; Ennis FA
    N Engl J Med; 2002 Apr; 346(17):1275-80. PubMed ID: 11923489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A; Baljer G; Wagner C; Sailer J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The persistence of neutralizing antibodies after revaccination against smallpox.
    el-Ad B; Roth Y; Winder A; Tochner Z; Lublin-Tennenbaum T; Katz E; Schwartz T
    J Infect Dis; 1990 Mar; 161(3):446-8. PubMed ID: 2155973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphologic and serologic evaluation of the reaction to smallpox revaccination with special reference to virus neutralizing antibodies].
    Herrlich A; Adldinger H; Möbest H
    Dtsch Med Wochenschr; 1965 Dec; 90(50):2225-9. PubMed ID: 4285228
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].
    Bricaire F; Combadière B; Rouleau E; Bossi P; Garin D; Lebrun-Vignes B; Autran B
    Bull Acad Natl Med; 2006; 190(4-5):1035-46; discussion 1046-9. PubMed ID: 17195626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adaptation and cultivation of the Perego strain of ovine smallpox virus in tissue culture and an evaluation of its immunogenic properties].
    Mateva V; Stoĭchev S
    Vet Med Nauki; 1975; 12(10):18-23. PubMed ID: 173075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
    Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
    Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
    Hsieh SM; Chen SY; Sheu GC; Hung MN; Chou WH; Chang SC; Hsu KH
    Vaccine; 2006 Jan; 24(4):510-5. PubMed ID: 16139395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunological comparison of smallpox vaccine administered to the outer versus the inner upper arms of vaccinia-naive adults.
    Waibel KH; Golding H; Manischewitz J; King LR; Tuchscherer M; Topolski RL; Walsh DS
    Clin Infect Dis; 2006 Feb; 42(4):e16-20. PubMed ID: 16421781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.
    Wiser I; Balicer RD; Cohen D
    Vaccine; 2007 Jan; 25(6):976-84. PubMed ID: 17074424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antivariola vaccination. Technics for the mitigation of local and general reactions. Practical experience].
    Pazienza AM
    Ann Sclavo; 1975 SEP-OCT; 17(5):706-16. PubMed ID: 182093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of smallpox antibody levels of sera from samples of the vaccinated adult population of Madras.
    DOWNIE AW; HOBDAY TL; ST VINCENT L; KEMPE CH
    Bull World Health Organ; 1961; 25(1):55-61. PubMed ID: 13887635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune response in virus diseases on the model of smallpox].
    Ehrengut W
    Dtsch Med Wochenschr; 1971 Apr; 96(18):795-8. PubMed ID: 4324850
    [No Abstract]   [Full Text] [Related]  

  • 17. [Unsuccessful and successful nodular and pustular reactions following revaccination against smallpox. 3. Studies of antibody levels by neutralization test (N.-T.)].
    Möbest H
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Nov; 134(2):109-19. PubMed ID: 4233314
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-dependent neutralizing-antibody responses to vaccinia.
    Belshe RB; Newman FK; Frey SE; Couch RB; Treanor JJ; Tacket CO; Yan L
    J Infect Dis; 2004 Feb; 189(3):493-7. PubMed ID: 14745707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing challenges for allergists in vaccination to protect against smallpox.
    Hackett CJ; Rotrosen D; Plaut M
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):1-3. PubMed ID: 15702805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.